Notice to Extend Expiration Date for PAR-21-166 "Academic-Industrial Partnerships for Translation of Technologies for Diagnosis and Treatment (R01 - Clinical Trial Not Allowed)" and PAR-21-206 “Academic-Industrial Partnerships for Translation of Technologies for Diagnosis and Treatment (R01 - Clinical Trial Optional)”
Notice Number:
NOT-CA-24-069
Release Date:
June 26, 2024
Related Announcements
- March 25, 2021 - Academic-Industrial Partnerships for Translation of Technologies for Diagnosis and Treatment (R01 - Clinical Trial Not Allowed). See NOFO PAR-21-166.
- March 25, 2021 - Academic-Industrial Partnerships for Translation of Technologies for Diagnosis and Treatment (R01 - Clinical Trial Optional). See NOFO PAR-21-206.
Issued by
National Cancer Institute (NCI)
Purpose
This purpose of this notice is to extend the expiration date for the following funding opportunities:
- NOFO #1: PAR-21-166 - Academic-Industrial Partnerships for Translation of Technologies for Diagnosis and Treatment (R01 - Clinical Trial Not Allowed).
- NOFO #2: PAR-21-206 - Academic-Industrial Partnerships for Translation of Technologies for Diagnosis and Treatment (R01 - Clinical Trial Optional).
With the addition/extension by one Application Due Date, the above NOFOs now expire on January 8, 2025. The changes are in bold and italics in the table below.
Application Due Dates | Review and Award Cycles | ||||
| New | Renewal / Resubmission / Revision (as allowed) | AIDS | Scientific Merit Review | Advisory Council Review | Earliest Start Date |
| June 05, 2021* | July 05, 2021* | Not Applicable | November 2021 | January 2022 | April 2022 |
| October 05, 2021* | November 05, 2021* | Not Applicable | March 2022 | May 2022 | July 2022 |
| February 05, 2022* | March 05, 2022* | Not Applicable | July 2022 | October 2022 | December 2022 |
| June 05, 2022* | July 05, 2022* | Not Applicable | November 2022 | January 2023 | April 2023 |
| October 05, 2022* | November 05, 2022* | Not Applicable | March 2023 | May 2023 | July 2023 |
| February 05, 2023* | March 05, 2023* | Not Applicable | July 2023 | October 2023 | December 2023 |
| June 05, 2023* | July 05, 2023* | Not Applicable | November 2023 | January 2024 | April 2024 |
| October 05, 2023* | November 05, 2023* | Not Applicable | March 2024 | May 2024 | July 2024 |
| February 05, 2024* | March 05, 2024* | Not Applicable | July 2024 | October 2024 | December 2024 |
| June 05, 2024* | July 05, 2024* | Not Applicable | November 2024 | January 2025 | April 2025 |
| October 05, 2024* | November 05, 2024* | Not Applicable | March 2025 | May 2025 | July 2025 |
Expiration Date: January 8, 2025, per issuance of NOT-CA-24-069 (Previous expiration date September 8, 2024).
All other aspects of the opportunity(ies) remain the same.
Inquiries
Please direct all inquiries to:
Miguel R. Ossandon, Ph.D.
National Cancer Institute (NCI)
Telephone: 240-276-5714
Email: ossandom@mail.nih.gov
Department of Health
and Human Services (HHS)
and Human Services (HHS)
